• Fri, August 9, 2024
Luca Issi Maintained (VERV) at Buy with Decreased Target to $20 on, Aug 9th, 2024
Luca Issi of RBC Capital, Maintained "Verve Therapeutics, Inc." (VERV) at Buy with Decreased Target from $25 to $20 on, Aug 9th, 2024.
Luca has made no other calls on VERV in the last 4 months.
There is 1 other peer that has a rating on VERV. Out of the 1 peers that are also analyzing VERV, 0 agree with Luca's Rating of Hold.
This is the rating of the analyst that currently disagrees with Luca
- Mitchell Kapoor of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $15 on, Thursday, May 9th, 2024
Like: 👍
